Effect of SGLT2 Inhibitors on the Sympathetic Nervous System and Blood Pressure

被引:0
作者
André J. Scheen
机构
[1] University of Liège,Division of Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, CHU Liège
[2] University of Liège,Clinical Pharmacology Unit, CHU Liège, Center for Interdisciplinary Research on Medicines (CIRM)
来源
Current Cardiology Reports | 2019年 / 21卷
关键词
Blood pressure; Diuretic; Hypertension; SGLT2 inhibitor; Sympathetic nervous system; Type 2 diabetes;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 567 条
[1]  
Vecchione C(2000)Sympathetic nervous system and hypertension in diabetic patients Diabetes Nutr Metab 13 327-331
[2]  
Argenziano L(2015)The sympathetic nervous system alterations in human hypertension Circ Res 116 976-990
[3]  
Fratta L(2012)The human sympathetic nervous system: its relevance in hypertension and heart failure Eur Heart J 33 1058-1066
[4]  
Grassi G(2017)Contribution of autonomic reflexes to the hyperadrenergic state in heart failure Front Neurosci 11 162-1378
[5]  
Mark A(2017)The autonomic nervous system as a therapeutic target in heart failure: a scientific position statement from the translational research Committee of the Heart Failure Association of the European Society of Cardiology Eur J Heart Fail 19 1361-610
[6]  
Esler M(2012)Diabetes and hypertension: the bad companions Lancet 380 601-323
[7]  
Parati G(2018)The heart failure burden of type 2 diabetes mellitus-a review of pathophysiology and interventions Heart Fail Rev 23 303-157
[8]  
Esler M(2019)Obesity and its cardiovascular effects Diabetes Metab Res Rev 35 e3135-3101
[9]  
Toschi-Dias E(2017)Factors responsible for obesity-related hypertension Curr Hypertens Rep 19 53-67
[10]  
Rondon M(2015)Metabolic syndrome: a sympathetic disease? Lancet Diabetes Endocrinol 3 148-59